Literature DB >> 22100615

Animal models of adrenocortical tumorigenesis.

Felix Beuschlein1, Sara Galac, David B Wilson.   

Abstract

Over the past decade, research on human adrenocortical neoplasia has been dominated by gene expression profiling of tumor specimens and by analysis of genetic disorders associated with a predisposition to these tumors. Although these studies have identified key genes and associated signaling pathways that are dysregulated in adrenocortical neoplasms, the molecular events accounting for the frequent occurrence of benign tumors and low rate of malignant transformation remain unknown. Moreover, the prognosis for patients with adrenocortical carcinoma remains poor, so new medical treatments are needed. Naturally occurring and genetically engineered animal models afford a means to investigate adrenocortical tumorigenesis and to develop novel therapeutics. This comparative review highlights adrenocortical tumor models useful for either mechanistic studies or preclinical testing. Three model species - mouse, ferret, and dog - are reviewed, and their relevance to adrenocortical tumors in humans is discussed. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22100615      PMCID: PMC3288624          DOI: 10.1016/j.mce.2011.09.045

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  101 in total

1.  Neoplastic diseases in ferrets: 574 cases (1968-1997).

Authors:  X Li; J G Fox; P A Padrid
Journal:  J Am Vet Med Assoc       Date:  1998-05-01       Impact factor: 1.936

2.  Correlation between age at neutering and age at onset of hyperadrenocorticism in ferrets.

Authors:  N J Shoemaker; M Schuurmans; H Moorman; J T Lumeij
Journal:  J Am Vet Med Assoc       Date:  2000-01-15       Impact factor: 1.936

3.  Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis.

Authors:  A F Gazdar; H K Oie; C H Shackleton; T R Chen; T J Triche; C E Myers; G P Chrousos; M F Brennan; C A Stein; R V La Rocca
Journal:  Cancer Res       Date:  1990-09-01       Impact factor: 12.701

Review 4.  Adrenal gland: structure, function, and mechanisms of toxicity.

Authors:  T J Rosol; J T Yarrington; J Latendresse; C C Capen
Journal:  Toxicol Pathol       Date:  2001 Jan-Feb       Impact factor: 1.902

5.  A polymorphic form of steroidogenic factor-1 is associated with adrenocorticotropin resistance in y1 mouse adrenocortical tumor cell mutants.

Authors:  Claudia Frigeri; Jennivine Tsao; Martha Cordova; Bernard P Schimmer
Journal:  Endocrinology       Date:  2002-10       Impact factor: 4.736

Review 6.  Cushing's syndrome variants secondary to aberrant hormone receptors.

Authors:  André Lacroix; Valérie Baldacchino; Isabelle Bourdeau; Pavel Hamet; Johanne Tremblay
Journal:  Trends Endocrinol Metab       Date:  2004-10       Impact factor: 12.015

Review 7.  Gonadectomy-induced adrenocortical neoplasia in the domestic ferret (Mustela putorius furo) and laboratory mouse.

Authors:  M Bielinska; S Kiiveri; H Parviainen; S Mannisto; M Heikinheimo; D B Wilson
Journal:  Vet Pathol       Date:  2006-03       Impact factor: 2.221

8.  Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin alpha knockout mice.

Authors:  Kathleen H Burns; Julio E Agno; Piotr Sicinski; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2003-07-10

9.  Effect of trilostane on serum concentrations of aldosterone, cortisol, and potassium in dogs with pituitary-dependent hyperadrenocorticism.

Authors:  Monique Wenger; Nadja S Sieber-Ruckstuhl; Claudia Müller; Claudia E Reusch
Journal:  Am J Vet Res       Date:  2004-09       Impact factor: 1.156

10.  Results of adrenalectomy in 36 dogs with hyperadrenocorticism caused by adreno-cortical tumour.

Authors:  F J van Sluijs; B E Sjollema; G Voorhout; T S van den Ingh; A Rijnberk
Journal:  Vet Q       Date:  1995-09       Impact factor: 3.320

View more
  7 in total

Review 1.  Toying with fate: Redirecting the differentiation of adrenocortical progenitor cells into gonadal-like tissue.

Authors:  Theresa Röhrig; Marjut Pihlajoki; Ricarda Ziegler; Rebecca S Cochran; Anja Schrade; Maximiliaan Schillebeeckx; Robi D Mitra; Markku Heikinheimo; David B Wilson
Journal:  Mol Cell Endocrinol       Date:  2014-12-08       Impact factor: 4.102

Review 2.  GATA factors in endocrine neoplasia.

Authors:  Marjut Pihlajoki; Anniina Färkkilä; Tea Soini; Markku Heikinheimo; David B Wilson
Journal:  Mol Cell Endocrinol       Date:  2015-05-28       Impact factor: 4.102

3.  GATA4 is a critical regulator of gonadectomy-induced adrenocortical tumorigenesis in mice.

Authors:  Justyna Krachulec; Melanie Vetter; Anja Schrade; Ann-Kathrin Löbs; Malgorzata Bielinska; Rebecca Cochran; Antti Kyrönlahti; Marjut Pihlajoki; Helka Parviainen; Patrick Y Jay; Markku Heikinheimo; David B Wilson
Journal:  Endocrinology       Date:  2012-03-28       Impact factor: 4.736

4.  Novel markers of gonadectomy-induced adrenocortical neoplasia in the mouse and ferret.

Authors:  Maximiliaan Schillebeeckx; Marjut Pihlajoki; Elisabeth Gretzinger; Wei Yang; Franziska Thol; Theresa Hiller; Ann-Kathrin Löbs; Theresa Röhrig; Anja Schrade; Rebecca Cochran; Patrick Y Jay; Markku Heikinheimo; Robi D Mitra; David B Wilson
Journal:  Mol Cell Endocrinol       Date:  2014-10-05       Impact factor: 4.102

Review 5.  Adrenocortical zonation, renewal, and remodeling.

Authors:  Marjut Pihlajoki; Julia Dörner; Rebecca S Cochran; Markku Heikinheimo; David B Wilson
Journal:  Front Endocrinol (Lausanne)       Date:  2015-03-05       Impact factor: 5.555

6.  Establishment of a mouse xenograft model of metastatic adrenocortical carcinoma.

Authors:  Aurélie Morin; Carmen Ruggiero; Estelle Robidel; Mabrouka Doghman-Bouguerra; Atze T Das; Rémy Castellano; Emmanuelle Josselin; Judith Favier; Enzo Lalli
Journal:  Oncotarget       Date:  2017-04-07

Review 7.  All lesions great and small, part 2. Diagnostic cytology in veterinary medicine.

Authors:  Leslie C Sharkey; Davis M Seelig; Jed Overmann
Journal:  Diagn Cytopathol       Date:  2014-02-19       Impact factor: 1.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.